Investor Relations
TOP IR CONTENTS
The Latest Presentation Materials
Past Presentation MaterialsConference on FY2026.12 Q3 Financial Results
FY2026 Q3 Overview
Dr. Osamu Okuda,
President & CEO
FY2026 Q3 Overview of Development Pipeline
Tsukasa Kusano,
Executive Vice President, Head of Project & Lifecycle Management Unit
FY2026 Q3 Consolidated Financial Overview (Core)
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
Upcoming Events(Upcoming Events (2 Most Recent))
Events & PresentationsAnnual Report 2025(Integrated Report)
Past Annual Report
What's New
-
Conference on FY 2026.12 Q3 Financial Results
-
Financial Results for Third Quarter of Fiscal Year 2026 (Jan-Sep 2026)
-
Transcript (including Q&A) for Conference on FY2026.12 Q2 Financial Results
-
Financial Results for Second Quarter of Fiscal Year 2026 (Jan-Jun 2026)
-
Conference on FY 2026.12 Q2 Financial Results
-
Chugai Announces 2026 3rd Quarter Results
-
Roche’s Announcement Regarding Sefaxersen (Detailed Interim Analysis Data from the Phase III IMAgINATION Study)
-
Roche's Announcement Regarding divarasib (Presentation of Latest Data in KRAS G12C-Positive Non-Small Cell Lung Cancer at ESMO)
-
F. Hoffmann-La Roche Announces Third Quarter Sales 2026
-
Chugai Receives Porter Prize 2026
External Evaluations
External Evaluations-
ESG Indices of Global Equities
DJSI is a leading ESG index developed by S&P Dow Jones Indices (USA). Companies are selected as a constituent annually based on an assessment of their economic, environmental and social sustainability.
-
ESG Indices Selected by GPIF
Chugai has been continuously included as a constituent stock of the all six ESG indices for Japanese equities since the initiation of ESG investment by the Government Pension Investment Fund (GPIF).
-
IR Activities
Chugai was ranked first for the first time in 2024 in the pharmaceutical sector for the “Selection of Excellent Companies in Corporate Disclosure by Securities Analysts” conducted by the Securities Analysts Association of Japan (SAAJ), a public interest incorporated association.
About Chugai
-
Company Outline
Company Profile, Business Process, Directors & Officers, Organization.
-
History of Chugai Pharmaceutical
Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”
-
R&D
Easy-to-understand introduction of Chugai’s R&D structure, strategies and technologies.
